HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberta Rogowski Selected Research

Doxepin (Mareen)

2/2012Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.
10/2011Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.
7/2011A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation.
11/2010Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
10/2010Efficacy and safety of doxepin 6 mg in a model of transient insomnia.
10/2008Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
11/2007Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberta Rogowski Research Topics

Disease

7Sleep Initiation and Maintenance Disorders (Insomnia)
02/2012 - 11/2007
2Weight Gain
10/2011 - 11/2010

Drug/Important Bio-Agent (IBA)

7Doxepin (Mareen)FDA LinkGeneric
02/2012 - 11/2007
2Cholinergic Antagonists (Anticholinergics)IBA
10/2011 - 11/2010
2TabletsIBA
07/2011 - 10/2010
1Histamine (Histamine Dihydrochloride)FDA Link
02/2012

Therapy/Procedure

1Therapeutics
07/2011
1Drug Therapy (Chemotherapy)
11/2010